The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hidradenitis Suppurativa Treatment Market Research Report 2025
Synopsis
Hidradenitis suppurativa (HS) is a painful, long-term skin condition that causes abscesses and scarring on the skin.
The exact cause of hidradenitis suppurativa is unknown, but it occurs near hair follicles where there are sweat glands, usually around the groin, bottom, breasts and armpits.
There's no cure for HS, but treatments and lifestyle changes can bring some relief and cut down on flare-ups.
The global Hidradenitis Suppurativa Treatment market was valued at US$ 643.3 million in 2023 and is anticipated to reach US$ 860.9 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The classification of Hidradenitis Suppurativa Treatment includes Medications, Surgery and others, and the proportion of Medications in 2019 is about 76%.
Hidradenitis Suppurativa Treatment is widely used in Hospital, Clinical and other field. The most proportion of Hidradenitis Suppurativa Treatment is Hospital, and the proportion in 2019 is 53.53%.
Europe is the largest consumption place with a consumption market share of 47.76% in 2019. Following Europe, Asia Pacific is the second largest consumption place with the consumption market share of 23.97%.
Market competition is intense. AbbVie, Merck, Pfizer, AstraZeneca, GlaxoSmithKline, etc. are the leaders of the industry.
This report aims to provide a comprehensive presentation of the global market for Hidradenitis Suppurativa Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hidradenitis Suppurativa Treatment.
Report Scope
The Hidradenitis Suppurativa Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hidradenitis Suppurativa Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hidradenitis Suppurativa Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Merck
Pfizer
AstraZeneca
GlaxoSmithKline
Perrigo
Sun Pharma
Almirall
Bausch Health
Johnson & Johnson
Segment by Type
Medications
Surgery
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hidradenitis Suppurativa Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Hidradenitis suppurativa (HS) is a painful, long-term skin condition that causes abscesses and scarring on the skin.
The exact cause of hidradenitis suppurativa is unknown, but it occurs near hair follicles where there are sweat glands, usually around the groin, bottom, breasts and armpits.
There's no cure for HS, but treatments and lifestyle changes can bring some relief and cut down on flare-ups.
The global Hidradenitis Suppurativa Treatment market was valued at US$ 643.3 million in 2023 and is anticipated to reach US$ 860.9 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The classification of Hidradenitis Suppurativa Treatment includes Medications, Surgery and others, and the proportion of Medications in 2019 is about 76%.
Hidradenitis Suppurativa Treatment is widely used in Hospital, Clinical and other field. The most proportion of Hidradenitis Suppurativa Treatment is Hospital, and the proportion in 2019 is 53.53%.
Europe is the largest consumption place with a consumption market share of 47.76% in 2019. Following Europe, Asia Pacific is the second largest consumption place with the consumption market share of 23.97%.
Market competition is intense. AbbVie, Merck, Pfizer, AstraZeneca, GlaxoSmithKline, etc. are the leaders of the industry.
This report aims to provide a comprehensive presentation of the global market for Hidradenitis Suppurativa Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hidradenitis Suppurativa Treatment.
Report Scope
The Hidradenitis Suppurativa Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hidradenitis Suppurativa Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hidradenitis Suppurativa Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Merck
Pfizer
AstraZeneca
GlaxoSmithKline
Perrigo
Sun Pharma
Almirall
Bausch Health
Johnson & Johnson
Segment by Type
Medications
Surgery
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hidradenitis Suppurativa Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hidradenitis Suppurativa Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medications
1.2.3 Surgery
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hidradenitis Suppurativa Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hidradenitis Suppurativa Treatment Market Perspective (2019-2030)
2.2 Hidradenitis Suppurativa Treatment Growth Trends by Region
2.2.1 Global Hidradenitis Suppurativa Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hidradenitis Suppurativa Treatment Historic Market Size by Region (2019-2024)
2.2.3 Hidradenitis Suppurativa Treatment Forecasted Market Size by Region (2025-2030)
2.3 Hidradenitis Suppurativa Treatment Market Dynamics
2.3.1 Hidradenitis Suppurativa Treatment Industry Trends
2.3.2 Hidradenitis Suppurativa Treatment Market Drivers
2.3.3 Hidradenitis Suppurativa Treatment Market Challenges
2.3.4 Hidradenitis Suppurativa Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hidradenitis Suppurativa Treatment Players by Revenue
3.1.1 Global Top Hidradenitis Suppurativa Treatment Players by Revenue (2019-2024)
3.1.2 Global Hidradenitis Suppurativa Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Hidradenitis Suppurativa Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hidradenitis Suppurativa Treatment Revenue
3.4 Global Hidradenitis Suppurativa Treatment Market Concentration Ratio
3.4.1 Global Hidradenitis Suppurativa Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hidradenitis Suppurativa Treatment Revenue in 2023
3.5 Hidradenitis Suppurativa Treatment Key Players Head office and Area Served
3.6 Key Players Hidradenitis Suppurativa Treatment Product Solution and Service
3.7 Date of Enter into Hidradenitis Suppurativa Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hidradenitis Suppurativa Treatment Breakdown Data by Type
4.1 Global Hidradenitis Suppurativa Treatment Historic Market Size by Type (2019-2024)
4.2 Global Hidradenitis Suppurativa Treatment Forecasted Market Size by Type (2025-2030)
5 Hidradenitis Suppurativa Treatment Breakdown Data by Application
5.1 Global Hidradenitis Suppurativa Treatment Historic Market Size by Application (2019-2024)
5.2 Global Hidradenitis Suppurativa Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hidradenitis Suppurativa Treatment Market Size (2019-2030)
6.2 North America Hidradenitis Suppurativa Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hidradenitis Suppurativa Treatment Market Size by Country (2019-2024)
6.4 North America Hidradenitis Suppurativa Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hidradenitis Suppurativa Treatment Market Size (2019-2030)
7.2 Europe Hidradenitis Suppurativa Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hidradenitis Suppurativa Treatment Market Size by Country (2019-2024)
7.4 Europe Hidradenitis Suppurativa Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hidradenitis Suppurativa Treatment Market Size (2019-2030)
8.2 Asia-Pacific Hidradenitis Suppurativa Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hidradenitis Suppurativa Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Hidradenitis Suppurativa Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hidradenitis Suppurativa Treatment Market Size (2019-2030)
9.2 Latin America Hidradenitis Suppurativa Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hidradenitis Suppurativa Treatment Market Size by Country (2019-2024)
9.4 Latin America Hidradenitis Suppurativa Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hidradenitis Suppurativa Treatment Market Size (2019-2030)
10.2 Middle East & Africa Hidradenitis Suppurativa Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Hidradenitis Suppurativa Treatment Introduction
11.1.4 AbbVie Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Hidradenitis Suppurativa Treatment Introduction
11.2.4 Merck Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Hidradenitis Suppurativa Treatment Introduction
11.3.4 Pfizer Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Hidradenitis Suppurativa Treatment Introduction
11.4.4 AstraZeneca Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024)
11.4.5 AstraZeneca Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Hidradenitis Suppurativa Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Perrigo
11.6.1 Perrigo Company Detail
11.6.2 Perrigo Business Overview
11.6.3 Perrigo Hidradenitis Suppurativa Treatment Introduction
11.6.4 Perrigo Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024)
11.6.5 Perrigo Recent Development
11.7 Sun Pharma
11.7.1 Sun Pharma Company Detail
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma Hidradenitis Suppurativa Treatment Introduction
11.7.4 Sun Pharma Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024)
11.7.5 Sun Pharma Recent Development
11.8 Almirall
11.8.1 Almirall Company Detail
11.8.2 Almirall Business Overview
11.8.3 Almirall Hidradenitis Suppurativa Treatment Introduction
11.8.4 Almirall Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024)
11.8.5 Almirall Recent Development
11.9 Bausch Health
11.9.1 Bausch Health Company Detail
11.9.2 Bausch Health Business Overview
11.9.3 Bausch Health Hidradenitis Suppurativa Treatment Introduction
11.9.4 Bausch Health Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024)
11.9.5 Bausch Health Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Hidradenitis Suppurativa Treatment Introduction
11.10.4 Johnson & Johnson Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024)
11.10.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Hidradenitis Suppurativa Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Medications
Table 3. Key Players of Surgery
Table 4. Key Players of Others
Table 5. Global Hidradenitis Suppurativa Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Hidradenitis Suppurativa Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Hidradenitis Suppurativa Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Hidradenitis Suppurativa Treatment Market Share by Region (2019-2024)
Table 9. Global Hidradenitis Suppurativa Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Hidradenitis Suppurativa Treatment Market Share by Region (2025-2030)
Table 11. Hidradenitis Suppurativa Treatment Market Trends
Table 12. Hidradenitis Suppurativa Treatment Market Drivers
Table 13. Hidradenitis Suppurativa Treatment Market Challenges
Table 14. Hidradenitis Suppurativa Treatment Market Restraints
Table 15. Global Hidradenitis Suppurativa Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Hidradenitis Suppurativa Treatment Market Share by Players (2019-2024)
Table 17. Global Top Hidradenitis Suppurativa Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hidradenitis Suppurativa Treatment as of 2023)
Table 18. Ranking of Global Top Hidradenitis Suppurativa Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Hidradenitis Suppurativa Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hidradenitis Suppurativa Treatment Product Solution and Service
Table 22. Date of Enter into Hidradenitis Suppurativa Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hidradenitis Suppurativa Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global Hidradenitis Suppurativa Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global Hidradenitis Suppurativa Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global Hidradenitis Suppurativa Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America Hidradenitis Suppurativa Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Hidradenitis Suppurativa Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Hidradenitis Suppurativa Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Hidradenitis Suppurativa Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Hidradenitis Suppurativa Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Hidradenitis Suppurativa Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Hidradenitis Suppurativa Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Hidradenitis Suppurativa Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Hidradenitis Suppurativa Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Hidradenitis Suppurativa Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Hidradenitis Suppurativa Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Hidradenitis Suppurativa Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. AbbVie Company Detail
Table 48. AbbVie Business Overview
Table 49. AbbVie Hidradenitis Suppurativa Treatment Product
Table 50. AbbVie Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024) & (US$ Million)
Table 51. AbbVie Recent Development
Table 52. Merck Company Detail
Table 53. Merck Business Overview
Table 54. Merck Hidradenitis Suppurativa Treatment Product
Table 55. Merck Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024) & (US$ Million)
Table 56. Merck Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Hidradenitis Suppurativa Treatment Product
Table 60. Pfizer Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. AstraZeneca Company Detail
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Hidradenitis Suppurativa Treatment Product
Table 65. AstraZeneca Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024) & (US$ Million)
Table 66. AstraZeneca Recent Development
Table 67. GlaxoSmithKline Company Detail
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline Hidradenitis Suppurativa Treatment Product
Table 70. GlaxoSmithKline Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024) & (US$ Million)
Table 71. GlaxoSmithKline Recent Development
Table 72. Perrigo Company Detail
Table 73. Perrigo Business Overview
Table 74. Perrigo Hidradenitis Suppurativa Treatment Product
Table 75. Perrigo Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024) & (US$ Million)
Table 76. Perrigo Recent Development
Table 77. Sun Pharma Company Detail
Table 78. Sun Pharma Business Overview
Table 79. Sun Pharma Hidradenitis Suppurativa Treatment Product
Table 80. Sun Pharma Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024) & (US$ Million)
Table 81. Sun Pharma Recent Development
Table 82. Almirall Company Detail
Table 83. Almirall Business Overview
Table 84. Almirall Hidradenitis Suppurativa Treatment Product
Table 85. Almirall Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024) & (US$ Million)
Table 86. Almirall Recent Development
Table 87. Bausch Health Company Detail
Table 88. Bausch Health Business Overview
Table 89. Bausch Health Hidradenitis Suppurativa Treatment Product
Table 90. Bausch Health Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024) & (US$ Million)
Table 91. Bausch Health Recent Development
Table 92. Johnson & Johnson Company Detail
Table 93. Johnson & Johnson Business Overview
Table 94. Johnson & Johnson Hidradenitis Suppurativa Treatment Product
Table 95. Johnson & Johnson Revenue in Hidradenitis Suppurativa Treatment Business (2019-2024) & (US$ Million)
Table 96. Johnson & Johnson Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hidradenitis Suppurativa Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hidradenitis Suppurativa Treatment Market Share by Type: 2023 VS 2030
Figure 3. Medications Features
Figure 4. Surgery Features
Figure 5. Others Features
Figure 6. Global Hidradenitis Suppurativa Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Hidradenitis Suppurativa Treatment Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Hidradenitis Suppurativa Treatment Report Years Considered
Figure 12. Global Hidradenitis Suppurativa Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Hidradenitis Suppurativa Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Hidradenitis Suppurativa Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Hidradenitis Suppurativa Treatment Market Share by Players in 2023
Figure 16. Global Top Hidradenitis Suppurativa Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hidradenitis Suppurativa Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Hidradenitis Suppurativa Treatment Revenue in 2023
Figure 18. North America Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Hidradenitis Suppurativa Treatment Market Share by Country (2019-2030)
Figure 20. United States Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Hidradenitis Suppurativa Treatment Market Share by Country (2019-2030)
Figure 24. Germany Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Hidradenitis Suppurativa Treatment Market Share by Region (2019-2030)
Figure 32. China Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Hidradenitis Suppurativa Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Hidradenitis Suppurativa Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Hidradenitis Suppurativa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. AbbVie Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2019-2024)
Figure 47. Merck Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2019-2024)
Figure 49. AstraZeneca Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2019-2024)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2019-2024)
Figure 51. Perrigo Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2019-2024)
Figure 52. Sun Pharma Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2019-2024)
Figure 53. Almirall Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2019-2024)
Figure 54. Bausch Health Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2019-2024)
Figure 55. Johnson & Johnson Revenue Growth Rate in Hidradenitis Suppurativa Treatment Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
